Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rivaroxaban vs Warfarin for Post-MI LV Thrombus (WaRMIN)
NCT05794399Phase 4Recruiting
- Sponsor
- Shahid Gangalal National Heart Centre
- Start
- Jun 2023
- Primary completion
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of rivaroxaban in left ventricular thrombus (LVT), sponsored by Shahid Gangalal National Heart Centre. Started Jun 2023; status: recruiting.
02
Drugs
rivaroxaban
03
Conditions
left ventricular thrombus (LVT)
Beyond the preview
Go deeper on NCT05794399.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05794399.